Baker McKenzie successfully acted for Mediland Pharm, a leading cosmetics and health products retailer on its IPO and ASX listing
Baker McKenzie successfully acted for Mediland Pharm Limited (MPH), a cosmetics and health products retailer servicing the Chinese inbound tourism sector in Australia, on its IPO and listing on the ASX. The initial market capitalisation for the Company came in at AUD$62.5 million.
Mediland was founded in 2002 and over the past 16 years has become a market leading retailer for the growing Chinese tourism sector, selling branded cosmetic and health products that are manufactured in Australia and a selection of wool products and jewelry.